Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

Clinical trial NCT00490945 · COMPLETED

Trial details

NCT number: NCT00490945
Sponsor: Vanda Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Circadian Rhythm Sleep Disorders

Start date: 2004-07-01
Primary completion: 2005-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.